Shannon L. Puhalla

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

Véronique Dièras, Hyo S. Han, Bella Kaufman et al. · The Lancet Oncology · 2020 · 321 citations · Full text

Medicine, Oncology, Pharmacology +10

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

Peilu Wang, Amir Bahreini, Rekha Gyanchandani et al. · Clinical Cancer Research · 2015 · 204 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Jiuping Ji, Robert J. Morgan et al. · Clinical Cancer Research · 2012 · 201 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

Molly Klein, David J. Dabbs, Yongli Shuai et al. · Modern Pathology · 2013 · 194 citations · Full text

Medicine, Oncology, Pathology +17